Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKCA | AMGN | BMY | GILD | VRTX |
| Company | Akcea Therapeutics Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 18.15 | 262.21 | 57.66 | 93.17 | 407.20 |
| High | 18.17 | 264.73 | 58.07 | 94.55 | 411.29 |
| Low | 18.13 | 261.76 | 57.51 | 92.97 | 406.02 |
| Last | 18.17 | 263.18 | 58.00 | 94.41 | 410.65 |
| Change | +0.03 | -1.31 | +0.24 | +0.46 | +2.47 |
| % Change | +0.17% | -0.50% | +0.42% | +0.49% | +0.61% |
| Volume | 815,300 | 1,637,600 | 4,689,300 | 2,915,600 | 1,191,500 |
| 20-Day Average Volume | 661,490 | 4,232,055 | 11,254,250 | 7,098,780 | 1,825,865 |
| Previous Close | 18.14 | 264.49 | 57.76 | 93.95 | 408.18 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.14 | 271.17 | 57.83 | 92.46 | 449.18 |
| 20-Day Raw Stochastic | 70.59% | 32.56% | 58.63% | 95.64% | 33.26% |
| 20-Day Relative Strength | 73.10% | 32.72% | 54.81% | 59.21% | 35.06% |
| Weighted Alpha | -23.90 | -15.18 | +21.20 | +26.94 | -7.12 |
| Today's Opinion | 72% Buy | 88% Sell | 96% Buy | 100% Buy | 72% Sell |
| Previous Opinion | 64% Buy | 88% Sell | 80% Buy | 100% Buy | 72% Sell |
| Last Month's Opinion | 8% Buy | 72% Sell | 100% Buy | 80% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.22% since 10/02/20 | +1.70% since 12/18/24 | +2.04% since 12/18/24 | +4.10% since 12/18/24 | -8.23% since 12/18/24 |
| Low | 18.08 on 10/05/20 | 253.30 on 12/19/24 | 56.08 on 12/20/24 | 90.27 on 12/19/24 | 377.85 on 12/19/24 |
| High | 18.17 on 10/09/20 | 269.61 on 12/20/24 | 58.07 on 12/26/24 | 94.55 on 12/26/24 | 411.29 on 12/26/24 |
| 1-Month | |||||
| %Chg | +0.17% since 09/09/20 | -6.01% since 11/26/24 | -1.26% since 11/26/24 | +3.35% since 11/26/24 | -12.08% since 11/26/24 |
| Low | 18.05 on 09/21/20 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 | 377.85 on 12/19/24 |
| High | 18.22 on 09/28/20 | 283.64 on 11/29/24 | 60.09 on 12/03/24 | 94.65 on 12/11/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | +36.72% since 07/09/20 | -17.52% since 09/26/24 | +15.72% since 09/26/24 | +13.69% since 09/26/24 | -11.34% since 09/26/24 |
| Low | 9.81 on 08/05/20 | 253.30 on 12/19/24 | 50.71 on 09/27/24 | 82.82 on 10/01/24 | 377.85 on 12/19/24 |
| High | 19.65 on 08/31/20 | 329.17 on 10/11/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | +11.88% since 04/09/20 | -15.87% since 06/26/24 | +36.47% since 06/26/24 | +36.21% since 06/26/24 | -13.36% since 06/26/24 |
| Low | 9.81 on 08/05/20 | 253.30 on 12/19/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 | 377.85 on 12/19/24 |
| High | 19.65 on 08/31/20 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,846,054 | 142,172,096 | 117,147,504 | 117,086,688 | 105,118,176 |
| Shares Outstanding, K | 101,599 | 537,533 | 2,028,177 | 1,246,266 | 257,529 |
| Annual Sales | 488,540,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | 40,770,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 22,380,000 | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 2,771,900,000 |
| Last Quarter Net Income | -49,580,000 | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,045,400,000 |
| 60-Month Beta | 1.45 | 0.55 | 0.45 | 0.18 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.49 on 08/04/20 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 11/03/20 | 02/04/25 | 02/06/25 | 02/11/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | 0.770 on 12/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | 12/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.74 | 49.21 | 21.08 | 0.00 |